Keybanc Maintains Overweight on HCA Healthcare, Lowers Price Target to $435
Benzinga Newsdesk 3 months ago
Analyst RatingsNewsPrice TargetHot
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $475 to $435.
Keybanc analyst Matthew Gillmor maintains HCA Healthcare (NYSE:HCA) with a Overweight and lowers the price target from $475 to $435.